-
TH287 Radiosensitizes Castration-Resistant Prostate Cancer
2026-09-10
A 2026 study found that combining the MTH1 inhibitor TH287 with ionizing radiation reduced survival and increased apoptosis in PC-3 and DU-145 castration-resistant prostate cancer cells. The strongest effect occurred when radiation was delivered 12 hours after TH287 exposure, highlighting treatment sequence as an important variable in radiosensitization studies.
-
Gramine for TNBC Ferroptosis Research
2026-09-10
Gramine is a research-grade ferroptosis inducer for connecting TNBC viability loss with CUL3–MTDH signaling, ubiquitination, and lipid-peroxidation readouts. This workflow emphasizes fresh solution preparation, orthogonal target validation, rescue experiments, and troubleshooting for reproducible cancer biology research.
-
SAR131675: VEGFR-3 Inhibitor Workflow Guide
2026-09-09
Build robust VEGFR-3 assays with SAR131675 by connecting biochemical potency to receptor phosphorylation, lymphatic endothelial phenotypes, angiogenesis, and macrophage biology. This workflow also highlights formulation constraints, pathway-specific controls, and the translational limits of hepatic fibrosis and tumor models.
-
L-Threonine in ALP Assay Design
2026-09-09
L-Threonine is not merely a culture supplement: it is a controllable metabolic variable that can shape interpretation of alkaline phosphatase experiments. This guide connects threonine handling, metabolic profiling, and the mechanistic advantages of metal-free carbon-dot nanozyme assays.
-
Dimethyloxalylglycine (DMOG) Protocol Guide
2026-09-08
Dimethyloxalylglycine (DMOG), SKU A4506, provides a controlled chemical approach for hypoxia-inducible factor stabilization in cell-based oxygen-sensing, hypoxia signaling, and inflammation studies. This guide covers preparation, controls, and interpretation boundaries; the compound is for scientific research only and should not be used as a diagnostic, therapeutic, or universal in vivo dosing reagent.
-
FITC Goat Anti-Mouse IgG (H+L) Antibody
2026-09-08
A scenario-driven guide to selecting, handling, and interpreting FITC-based mouse IgG detection in immunofluorescence and flow cytometry. It explains how SKU K1201 can support reproducible phenotyping alongside cell viability, proliferation, and cytotoxicity assays.
-
Batimastat (BB-94): Reliable MMP Assays
2026-09-07
Learn how Batimastat (BB-94), SKU A2577, can help researchers distinguish MMP-dependent extracellular effects from nonspecific cytotoxicity in viability, invasion, tumor, and neuromuscular assays. The article connects quantitative potency, solvent handling, controls, and interpretation to practical laboratory decisions.
-
Protease Inhibitor Cocktail: Workflow Guide
2026-09-05
Protect labile proteins, phosphosignals, and protein complexes during cell and tissue disruption with an EDTA-free, broad-spectrum formulation. This guide translates a recent PCNSL single-cell study into practical extraction, immunoprecipitation, kinase-assay, and troubleshooting workflows.
-
Tanshinone IIA Pathways in Psoriasis: Study Insights
2026-09-05
This study combines network pharmacology, molecular docking, keratinocyte assays, and an imiquimod-induced mouse model to explain how tanshinone IIA from Xiao-Yin decoction may suppress psoriasis-associated inflammation. Its central contribution is linking IL-17/IL-23 signaling with the PTGS2/NF-κB/AP-1 axis and showing stronger pathway inhibition when tanshinone IIA is combined with methotrexate.
-
Diuron as a Translational Toxicology Probe
2026-09-04
Diuron is more than a photosynthesis inhibitor: it is a useful probe for connecting exposure chemistry, plant biology research, and emerging renal toxicology evidence. This article presents an evidence-centered framework for choosing assays and interpreting JAK2/STAT1-related findings without conflating biological systems.
-
PGF2α/PTGFR in Endometrial Breakdown
2026-09-04
A 2024 mouse menstrual-like model study identifies PGF2α/PTGFR as a major regulator of endometrial breakdown and vascular permeability after progesterone withdrawal. Its combination of pharmacological inhibition, vascular readouts, and HIF-1α promoter analysis links prostaglandin signaling to a defined transcriptional mechanism with relevance to menstrual biology.
-
Baicalin methyl ester: From Isolation to Barrier Proof
2026-09-03
Baicalin methyl ester connects flavonoid provenance with a structured strategy for proving intestinal barrier protection. This article explains how to interpret pathway, cytokine, tight-junction, and mucosal endpoints without confusing molecular activity with clinical efficacy.
-
2X HyperFusion High-Fidelity Master Mix for CRISPR PCR
2026-09-03
Use the 2X HyperFusion High-Fidelity Master Mix for accurate amplicon generation, blunt-end cloning, and CRISPR target verification when sequence integrity matters. Its premixed format combines proofreading performance, rapid cycling, and practical workflow control for translational cancer research assays.
-
Gingerenone A Reverses Sunitinib Resistance in RCC
2026-09-02
This study identifies gingerenone A as a metabolic inhibitor that targets LDHA-driven glycolysis in renal cell carcinoma and weakens the HIF-1α/VEGFA/VEGFR2 angiogenic axis. Its combination with sunitinib reduced drug resistance in cellular and animal models, providing a mechanistic rationale for metabolic adjuvant strategies rather than a clinically validated treatment.
-
Annexin V-FITC/7-AAD Apoptosis Kit Workflow
2026-09-02
Build a fast, two-parameter cell death analysis workflow with the Annexin V-FITC/7-AAD Apoptosis Kit. The assay separates viable, early apoptotic, late apoptotic, and membrane-compromised cells, making it especially useful for cytotoxicity studies and FLASH-radiotherapy research.